Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Freeman

Showing results (171-180 of 191) with videos related to

Pageof 20
Sort By:
Oncogene|March 8, 2018
Regulation of inside-out β1-integrin activation by CDCP1Sara G Pollan, Fangjin Huang, Jamie M Sperger, et al.
Cancers|October 14, 2018
Identification of the Transcription Factor Relationships Associated with Androgen Deprivation Therapy Response and Metastatic Progression in Prostate CancerNitya V Sharma, Kathryn L Pellegrini, Veronique Ouellet, et al.
Molecular Medicine (Cambridge, Mass.)|June 11, 2025
ONECUT2 reprograms neuroendocrine fate and is an actionable therapeutic target in small cell lung cancerMirian Gutiérrez, Irene Zamora, Raquel Iriarte, et al.
Oncotarget|November 12, 2016
Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cellsQinlong Li, Lijuan Yin, Lawrence W Jones, et al.
European Urology Open Science|May 31, 2022
Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified RaceKevin H Kensler, Shivanshu Awasthi, Mohamed Alshalalfa, et al.
The American Journal of Pathology|October 2, 2012
Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic diseaseDolores Di Vizio, Matteo Morello, Andrew C Dudley, et al.
Biomarker Research|January 16, 2026
Gene-body DNA methylation of ONECUT2 predicts its expression and prostate cancer aggressiveness in needle biopsiesYohei Sekino, Hong-Tao Li, Masatomo Kaneko, et al.
The Prostate|December 1, 2016
Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft ModelElizabeth M Masko, Mahmoud A Alfaqih, Keith R Solomon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2025
Emerin Dysregulation Drives the Very-Small-Nuclear Phenotype and Lineage Plasticity That Associate with a Clinically Aggressive Subtype of Prostate CancerLe Zhang, Pai-Chi Teng, Karen A Cavassani, et al.
Oncotarget|December 2, 2015
SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancerMurali Gururajan, Karen A Cavassani, Margarit Sievert, et al.
Pageof 20

Showing results (171-180 of 191) with videos related to

Sort By:
Pageof 20
Oncogene|March 8, 2018
Regulation of inside-out β1-integrin activation by CDCP1Sara G Pollan, Fangjin Huang, Jamie M Sperger, et al.
Cancers|October 14, 2018
Identification of the Transcription Factor Relationships Associated with Androgen Deprivation Therapy Response and Metastatic Progression in Prostate CancerNitya V Sharma, Kathryn L Pellegrini, Veronique Ouellet, et al.
Molecular Medicine (Cambridge, Mass.)|June 11, 2025
ONECUT2 reprograms neuroendocrine fate and is an actionable therapeutic target in small cell lung cancerMirian Gutiérrez, Irene Zamora, Raquel Iriarte, et al.
Oncotarget|November 12, 2016
Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cellsQinlong Li, Lijuan Yin, Lawrence W Jones, et al.
European Urology Open Science|May 31, 2022
Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified RaceKevin H Kensler, Shivanshu Awasthi, Mohamed Alshalalfa, et al.
The American Journal of Pathology|October 2, 2012
Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic diseaseDolores Di Vizio, Matteo Morello, Andrew C Dudley, et al.
Biomarker Research|January 16, 2026
Gene-body DNA methylation of ONECUT2 predicts its expression and prostate cancer aggressiveness in needle biopsiesYohei Sekino, Hong-Tao Li, Masatomo Kaneko, et al.
The Prostate|December 1, 2016
Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft ModelElizabeth M Masko, Mahmoud A Alfaqih, Keith R Solomon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2025
Emerin Dysregulation Drives the Very-Small-Nuclear Phenotype and Lineage Plasticity That Associate with a Clinically Aggressive Subtype of Prostate CancerLe Zhang, Pai-Chi Teng, Karen A Cavassani, et al.
Oncotarget|December 2, 2015
SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancerMurali Gururajan, Karen A Cavassani, Margarit Sievert, et al.
Pageof 20